Moderate to severe plaque psoriasis

Moderate to severe plaque psoriasis is a chronic, immune-mediated inflammatory skin disorder characterized by dysregulated keratinocyte proliferation driven by pro-inflammatory cytokine pathways Clinically, it manifests in pediatric or adult populations as well-demarcated, erythematous or hyperpigmented plaques covered with coarse, silvery-white scales that frequently cause pruritus, pain, and bleeding

Moderate to severe plaque psoriasis is a chronic, immune-mediated inflammatory skin disorder characterized by dysregulated keratinocyte proliferation driven by pro-inflammatory cytokine pathways The moderate-to-severe classification designates disease involving more than 3% to 10% of total body surface area, extensive disease activity reflected in elevated assessment scores, or localized lesions in high-impact areas such as the face, palms, soles, genitalia, or scalp that substantially impair ph...

Clinically, it manifests in pediatric or adult populations as well-demarcated, erythematous or hyperpigmented plaques covered with coarse, silvery-white scales that frequently cause pruritus, pain, and bleeding

Clinically, it manifests in pediatric or adult populations as well-demarcated, erythematous or hyperpigmented plaques covered with coarse, silvery-white scales that frequently cause pruritus, pain, and bleeding The moderate-to-severe classification designates disease involving more than 3% to 10% of total body surface area, extensive disease activity reflected in elevated assessment scores, or localized lesions in high-impact areas such as the face, palms, soles, genitalia, or scalp that substan...

The moderate-to-severe classification designates disease involving more than 3% to 10% of total body surface area, extensive disease activity reflected in elevated assessment scores, or localized lesions in high-impact areas such as the face, palms, soles, genitalia, or scalp that substantially impair physical function and quality of life

The moderate-to-severe classification designates disease involving more than 3% to 10% of total body surface area, extensive disease activity reflected in elevated assessment scores, or localized lesions in high-impact areas such as the face, palms, soles, genitalia, or scalp that substantially impair physical function and quality of life